Key Features

• Graded Pore Structure: Patented micro-meso-nano sizes for controlled fluid release.
• Optimal Composition: Synthetic hydroxyapatite and beta tricalcium phosphate (60:40 ratio) ensure bioactivity and resorption.
• Bead Size: 4–6 mm

Designed for infected bone sites, BONYX™ facilitates initial infection control while integrating with local bone, streamlining surgical procedures and meeting international safety standards.

 

Indications

BONYX™ is intended for:

• Filling open bone voids or defects from trauma or surgery (not load-bearing).
• Use in infected sites as a fluid-carrying scaffold, allowing for controlled infection management and promoting bone remodelling.

 

How It Works

1. Bone Void Filling:

Designed for open voids in the extremities, spine, and pelvis.
Composed of calcium phosphate bioceramics that integrate and get resorbed over time.

 

2. Infection Control:

Can be infused with appropriate antibiotics.
Controlled fluid release to the infection site during implantation.

 

Specific Applications Include:

• Osteomyelitis
• Cancellous Bone Augmentation
• Fluid Elution for Anti-Osteoporosis Treatments
• Local Chemotherapy for Bone Tumors (especially in the spine)
• TB of Spine and Related Pyogenic Tumors

 

Advantages of Calcium Phosphate Over Calcium Sulfate

Extended Fluid Release

Calcium phosphate systems maintain MIC-level antibiotic release for over 2 months, compared to the limited 3 to 8 weeks of calcium sulfate.

 

Optimal for Bone Healing

Ideal for antibiotic coverage during the 3 to 6 months needed for bone regeneration.

 

Better Biocompatibility

Calcium phosphate integrates more effectively with bone tissue & provides defect management, promoting healing.

 

Key Benefits

• Avoids multi-step procedures for infection control.
• Facilitates integration with local bone at the defect site.